Cognitive Training for Mild Cognitive Impairment
(COGIT-2 Trial)
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using certain medications that negatively impact cognition, like high doses of benzodiazepines, narcotics, or anticholinergics. If you are taking medications with anticholinergic or antihistaminergic properties, they will be reviewed to determine eligibility.
Research shows that computerized cognitive training can improve cognitive function in older adults with mild cognitive impairment, although the evidence is still limited and varies across different groups and cognitive areas.
12345Research suggests that computerized cognitive training is generally safe for older adults, including those with mild cognitive impairment or dementia.
34678Cognitive training is unique because it uses computer-based exercises to target specific brain functions and improve cognitive abilities through neuroplasticity (the brain's ability to reorganize itself). Unlike medications, which have generally not been successful for mild cognitive impairment, this approach focuses on enhancing brain function directly.
123910Eligibility Criteria
This trial is for people aged 55-89 with mild cognitive impairment (MCI), who have an informant to report on their functioning, access to a computer or tablet with internet, and can read English at a 6th-grade level. Women must be post-menopausal. Participants need documented memory impairment but still score above a certain threshold on a cognitive assessment.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive cognitive training with crosswords or health education for 12 weeks
Booster Sessions
Participants receive booster sessions of cognitive training or health education at specified intervals
Follow-up
Participants are monitored for safety and effectiveness after treatment